MitoQ Prevents Human Breast Cancer Recurrence and Lung Metastasis in Mice.
Published version
Peer-reviewed
Repository URI
Repository DOI
Change log
Authors
Abstract
In oncology, the occurrence of distant metastases often marks the transition from curative to palliative care. Such outcome is highly predictable for breast cancer patients, even if tumors are detected early, and there is no specific treatment to prevent metastasis. Previous observations indicated that cancer cell mitochondria are bioenergetic sensors of the tumor microenvironment that produce superoxide to promote evasion. Here, we tested whether mitochondria-targeted antioxidant MitoQ is capable to prevent metastasis in the MDA-MB-231 model of triple-negative human breast cancer in mice and in the MMTV-PyMT model of spontaneously metastatic mouse breast cancer. At clinically relevant doses, we report that MitoQ not only prevented metastatic take and dissemination, but also local recurrence after surgery. We further provide in vitro evidence that MitoQ does not interfere with conventional chemotherapies used to treat breast cancer patients. Since MitoQ already successfully passed Phase I safety clinical trials, our preclinical data collectively provide a strong incentive to test this drug for the prevention of cancer dissemination and relapse in clinical trials with breast cancer patients.
Description
Keywords
Journal Title
Conference Name
Journal ISSN
2072-6694
Volume Title
Publisher
Publisher DOI
Sponsorship
Fondation Belge contre le Cancer (Fundamental Research Grants #F86 and #FAF-F/2018/1282, N/A, Grants 7.4508.14 and 7.4529.17, grants FRSM 3.4567.10, FRFC 2.5025.12, CDR J.0135.18, U.G002.19)
Télévie (Grants 7.4508.14 and 7.4529.17)
Belgian Science Policy Office (Interuniversity Attraction Pole (IAP) grant #UP7-03)
Fund for Scientific Research (grants FRSM 3.4567.10, FRFC 2.5025.12, CDR J.0135.18, U.G002.19)
Communauté Française de Belgique (ARC 09/14-020 and ARC 14/19-058)
UCLouvain Fonds Spéciaux de la Recherche (FSR) (N/A)
Louvain Foundation (N/A)
Fonds Joseph Maisin (N/A)